The Arrow Group of Animal Hospitals in Central Arizona Partners with Vet-Stem, Inc. to Bring Stem Cell Therapy to Their Patients
The Arrow Group of Animal Hospitals, out of Glendale, Arizona and their 17 Phoenix Metro area veterinary hospitals have partnered with California based Vet-Stem, Inc., the leading Regenerative Veterinary Medicine company, to bring stem cell therapy to their patients. Dogs that are suffering pain or inflammation from osteoarthritis or polyarthritis, joint or ligament issues, or muscle injuries, can now receive stem cell therapy.
The Arrow Group of Animal Hospitals hosted Vet-Stem’s Corey Orava, DVM for a week of training sessions to help all of their staff learn the ins and outs of stem cell therapy. Veterinarians and technicians benefited from hands-on labs and a continuing education course that will help them bring the best care to their patients and pet owners. Under the mentorship of Dr. Orava, Dobson Ranch Animal Hospital, Fletcher Heights Animal Hospital, Surprise Animal Hospital and Animal Hospital at Anthem were able to perform their debut stem cell therapy cases during their initial week of offering the new service.
The Arrow Group of Animal Hospitals is a co-operative group of 17 individual small animal hospitals around the valley that are proud to offer the highest quality veterinary care possible. The doctors and staff at each hospital strive to build a long term relationship with their client families and their pets, always making recommendations in the pet’s best health interest. The Arrow Group of Animal Hospitals offer complete veterinary care from wellness, to vaccines, spays and neuters, dental, surgical and now regenerative medicine. Their animal hospital locations can be easily found at www.azpetvet.com.
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.’s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit www.vet-stem.com or call 858-748-2004.